Literature DB >> 354635

Clinical pharmacokinetics of theophylline.

R I Ogilvie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 354635     DOI： 10.2165/00003088-197803040-00002

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  138 in total

1.  The effects of aminophylline and other xanthines on the pulmonary circulation.

Authors:  C W QUIMBY; D M AVIADO; C F SCHMIDT
Journal:  J Pharmacol Exp Ther       Date:  1958-03       Impact factor: 4.030

2.  A rapid and precise method for determining theophylline in serum.

Authors:  C S Frings; R C Keefer; J M Saloom
Journal:  Clin Toxicol       Date:  1975       Impact factor: 4.467

3.  Effect of smoking on theophylline disposition.

Authors:  S N Hunt; W J Jusko; A M Yurchak
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875

4.  The influence of dietary methylxanthines on the metabolism and pharmacokinetics of intravenously administered theophylline [proceedings].

Authors:  J Caldwell; R Lancaster; T J Monks; R L Smith
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

5.  Intravenous aminophylline dosage. Use of serum theophylline measurement for guidance.

Authors:  M W Weinberger; R A Matthay; E J Ginchansky; C A Chidsey; T L Petty
Journal:  JAMA       Date:  1976-05-10       Impact factor: 56.272

6.  Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.

Authors:  J W Jenne; M S Wyze; F S Rood; F M MacDonald
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

7.  Pharmacologic effects of intravenously administered aminophylline in asthmatic children.

Authors:  R Maselli; G L Casal; E F Ellis
Journal:  J Pediatr       Date:  1970-05       Impact factor: 4.406

8.  Clinical toxocity of theophylline in relation to cigarette smoking. A report from the Boston Collaborative Drug Surveillance Program.

Authors:  H J Pfeifer; D J Greenblatt
Journal:  Chest       Date:  1978-04       Impact factor: 9.410

9.  Absolute bioavailability of oral theophylline.

Authors:  L Hendeles; M Weinberger; L Bighley
Journal:  Am J Hosp Pharm       Date:  1977-05

10.  Theophylline pharmacokinetics in premature infants with apnea.

Authors:  G Giacoia; W J Jusko; J Menke; J R Koup
Journal:  J Pediatr       Date:  1976-11       Impact factor: 4.406
View more
  106 in total

Review 1.  Research review. Interactions between environmental chemicals and drug biotransformation in man.

Authors:  A P Alvares
Journal:  Clin Pharmacokinet       Date:  1978 Nov-Dec       Impact factor: 6.447

2.  Theophylline steady state pharmacokinetics is not altered by omeprazole.

Authors:  A M Taburet; J Geneve; M Bocquentin; G Simoneau; C Caulin; E Singlas
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  Is diurnal variation in absorption of slow-release aminophylline an age-related phenomenon?

Authors:  A Rodgers; D N Bateman; K W Woodhouse
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  Theophylline pharmacokinetics after intravenous infusion with ethylenediamine or sodium glycinate.

Authors:  J Caldwell; A H Staib; I A Cotgreave; M Siebert-Weigel
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

5.  Enprofylline disposition in the presence and absence of amoxycillin or erythromycin.

Authors:  D S Sitar; F Y Aoki; D J Hoban; K G Hidinger; P R Montgomery; P A Mitenko
Journal:  Br J Clin Pharmacol       Date:  1987-07       Impact factor: 4.335

Review 6.  Combination bronchodilator therapy.

Authors:  G M Shenfield
Journal:  Drugs       Date:  1982-11       Impact factor: 9.546

7.  Metabolism of theophylline by cDNA-expressed human cytochromes P-450.

Authors:  H R Ha; J Chen; A U Freiburghaus; F Follath
Journal:  Br J Clin Pharmacol       Date:  1995-03       Impact factor: 4.335

8.  Combination of aminophylline (Phyllocontin Continus tablets) and salbutamol in the management of chronic obstructive airways disease.

Authors:  C J Clark; G Boyd
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

Review 9.  Theophylline poisoning. Pharmacological considerations and clinical management.

Authors:  P Gaudreault; J Guay
Journal:  Med Toxicol       Date:  1986 May-Jun

10.  In vitro effect of fluoroquinolones on theophylline metabolism in human liver microsomes.

Authors:  M Sarkar; R E Polk; P S Guzelian; C Hunt; H T Karnes
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.